The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults
Primary Purpose
Depression, Anxiety
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Alpha Stim device
Sham device
Sponsored by
About this trial
This is an interventional treatment trial for Depression
Eligibility Criteria
Inclusion Criteria:
- Competent (no legal guardian) males and females between the ages of 18 to 64
- Currently homeless or recent experience of homelessness, and symptoms of anxiety or depression
Exclusion Criteria:
- Younger than 18 and older than 65
- Patients who have attempted suicide with within the past twelve months or have active suicidal ideation will be excluded for possible safety concerns
- Self-reported illegal substance use in the past 30 days. Recent use of nicotine and alcohol will be allowed. However, those with current intoxication will be excluded
- History of a seizure disorder.
- Current history of autoimmune or endocrine disorder affecting the brain, unstable cardiac disease, history of skull fracture, or craniotomy
- Patients with pacemakers or internal electronic devices like deep brain stimulation and cochlear implants
- Women who are pregnant, nursing or planning to become pregnant
- Diagnosis of Schizophrenia or Schizoaffective disorder
Sites / Locations
- Wake Forest University Health Sciences
Arms of the Study
Arm 1
Arm 2
Arm Type
Sham Comparator
Active Comparator
Arm Label
Sham Device
Intervention
Arm Description
Sham device
CES device. cranial electrotherapy stimulation device. Alpha Stim device
Outcomes
Primary Outcome Measures
Depressive Symptoms
Hamilton Depression Rating Scale. The Hamilton Rating Scale for Depression is a multiple item questionnaire used to provide an indication of depression and as a guide to evaluate recovery (Hedlund, 1979). The questionnaire is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate moderate, severe, or very severe depression, and are usually required for entry into a clinical trial. Assessment time is estimated at 20 minutes (Hamilton, 1960). Higher values represent a worse outcome. The HAM-D form lists 21 items, the scoring is based on the first 17.Eight items are scored on a 5-point scale, ranging from 0 = not present to 4 = severe. Nine are scored from 0-2, with a total score range of 0-50.
Anxiety
Hamilton Anxiety Rating Scale. The Hamilton Anxiety Rating Scale (HAM-A) is a psychological questionnaire used by clinicians to rate the severity of a patient's anxiety (Hamilton, 1959; McDowell, Newell & & McDowell, 2006). The scale consists of 14 items designed to assess the severity of a patient's anxiety. Each of the 14 items contains a number of symptoms, and each group of symptoms is rated on a scale of zero to four, with four being the most severe (with a total score range of 0-56). All of these scores are used to compute an overarching score that indicates a person's anxiety severity (Vaccarino, 2008). A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity. Higher values represent a worse outcome.
Secondary Outcome Measures
Full Information
NCT ID
NCT02732561
First Posted
March 23, 2016
Last Updated
September 21, 2018
Sponsor
Wake Forest University Health Sciences
1. Study Identification
Unique Protocol Identification Number
NCT02732561
Brief Title
The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults
Official Title
The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety
Study Type
Interventional
2. Study Status
Record Verification Date
September 2018
Overall Recruitment Status
Completed
Study Start Date
March 2016 (undefined)
Primary Completion Date
June 2016 (Actual)
Study Completion Date
June 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Data Monitoring Committee
No
5. Study Description
Brief Summary
This is a trial of the use of cranial electrostimulating therapy for depression and anxiety among homeless adults.
Detailed Description
Cranial Electrostimulating (CES) Therapy is a Food and Drug Administration (FDA) approved treatment for depression and anxiety. However, there are no known studies on the use of this device with homeless adults. The objectives of this study are as follows: 1) to evaluate the acceptability and feasibility of CES as a treatment for homeless adults; and 2) to evaluate the efficacy of CES for the treatment of anxiety and depressive symptoms among homeless adults. Participants will be randomly assigned to one of two treatments: sham (n=10) or CES (n=10). Changes in anxiety and depressive symptoms will be evaluated over time.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Anxiety
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
10 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Sham Device
Arm Type
Sham Comparator
Arm Description
Sham device
Arm Title
Intervention
Arm Type
Active Comparator
Arm Description
CES device. cranial electrotherapy stimulation device. Alpha Stim device
Intervention Type
Device
Intervention Name(s)
Alpha Stim device
Intervention Description
cranial electrotherapy stimulation device
Intervention Type
Device
Intervention Name(s)
Sham device
Intervention Description
Sham device
Primary Outcome Measure Information:
Title
Depressive Symptoms
Description
Hamilton Depression Rating Scale. The Hamilton Rating Scale for Depression is a multiple item questionnaire used to provide an indication of depression and as a guide to evaluate recovery (Hedlund, 1979). The questionnaire is designed for adults and is used to rate the severity of their depression by probing mood, feelings of guilt, suicide ideation, insomnia, agitation or retardation, anxiety, weight loss, and somatic symptoms. A score of 0-7 is considered to be normal. Scores of 20 or higher indicate moderate, severe, or very severe depression, and are usually required for entry into a clinical trial. Assessment time is estimated at 20 minutes (Hamilton, 1960). Higher values represent a worse outcome. The HAM-D form lists 21 items, the scoring is based on the first 17.Eight items are scored on a 5-point scale, ranging from 0 = not present to 4 = severe. Nine are scored from 0-2, with a total score range of 0-50.
Time Frame
4 weeks
Title
Anxiety
Description
Hamilton Anxiety Rating Scale. The Hamilton Anxiety Rating Scale (HAM-A) is a psychological questionnaire used by clinicians to rate the severity of a patient's anxiety (Hamilton, 1959; McDowell, Newell & & McDowell, 2006). The scale consists of 14 items designed to assess the severity of a patient's anxiety. Each of the 14 items contains a number of symptoms, and each group of symptoms is rated on a scale of zero to four, with four being the most severe (with a total score range of 0-56). All of these scores are used to compute an overarching score that indicates a person's anxiety severity (Vaccarino, 2008). A score of 17 or less indicates mild anxiety severity. A score from 18 to 24 indicates mild to moderate anxiety severity. Lastly, a score of 25 to 30 indicates a moderate to severe anxiety severity. Higher values represent a worse outcome.
Time Frame
4 weeks
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
64 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Competent (no legal guardian) males and females between the ages of 18 to 64
Currently homeless or recent experience of homelessness, and symptoms of anxiety or depression
Exclusion Criteria:
Younger than 18 and older than 65
Patients who have attempted suicide with within the past twelve months or have active suicidal ideation will be excluded for possible safety concerns
Self-reported illegal substance use in the past 30 days. Recent use of nicotine and alcohol will be allowed. However, those with current intoxication will be excluded
History of a seizure disorder.
Current history of autoimmune or endocrine disorder affecting the brain, unstable cardiac disease, history of skull fracture, or craniotomy
Patients with pacemakers or internal electronic devices like deep brain stimulation and cochlear implants
Women who are pregnant, nursing or planning to become pregnant
Diagnosis of Schizophrenia or Schizoaffective disorder
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
James Kimball, MD
Organizational Affiliation
Wake Forest Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Wake Forest University Health Sciences
City
Winston-Salem
State/Province
North Carolina
ZIP/Postal Code
27117
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
The Efficacy of Cranial Electrostimulating Therapy for Depression and Anxiety Among Homeless Adults
We'll reach out to this number within 24 hrs